1EVK Stock Overview Produces specialty chemicals in the Asia-Pacific, Europe, the Middle East, Africa, Central and South America, and North America. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Add noteEvonik Industries AG Competitors Price History & Performance
Summary of share price highs, lows and changes for Evonik Industries Historical stock prices Current Share Price €16.40 52 Week High €21.26 52 Week Low €16.55 Beta 1.02 1 Month Change -6.47% 3 Month Change -19.55% 1 Year Change -10.97% 3 Year Change -41.61% 5 Year Change -39.12% Change since IPO -45.44%
Recent News & Updates
Third quarter 2024 earnings released: EPS: €0.48 (vs €0.21 loss in 3Q 2023) Nov 08
Evonik Industries AG to Report Q1, 2025 Results on May 12, 2025 Sep 20 Evonik Industries AG to Report Q2, 2025 Results on Aug 01, 2025
Second quarter 2024 earnings released: €0.01 loss per share (vs €0.58 loss in 2Q 2023) Aug 02
Upcoming dividend of €1.17 per share May 29
First quarter 2024 earnings released: EPS: €0.33 (vs €0.10 in 1Q 2023) May 09 See more updates
Third quarter 2024 earnings released: EPS: €0.48 (vs €0.21 loss in 3Q 2023) Nov 08
Evonik Industries AG to Report Q1, 2025 Results on May 12, 2025 Sep 20 Evonik Industries AG to Report Q2, 2025 Results on Aug 01, 2025
Second quarter 2024 earnings released: €0.01 loss per share (vs €0.58 loss in 2Q 2023) Aug 02
Upcoming dividend of €1.17 per share May 29
First quarter 2024 earnings released: EPS: €0.33 (vs €0.10 in 1Q 2023) May 09 Evonik Industries AG, Annual General Meeting, May 28, 2025
Full year 2023 earnings released: €1.00 loss per share (vs €1.16 profit in FY 2022) Mar 05
International Chemical Investors S.E. agreed to acquire Superabsorbents business of Evonik. Mar 05 Lanxess Reportedly Seeks to Sell Polyurethane Ops Jan 16
Third quarter 2023 earnings released: €0.21 loss per share (vs €0.46 profit in 3Q 2022) Nov 08
New minor risk - Share price stability Aug 13
Second quarter 2023 earnings released: €0.58 loss per share (vs €0.64 profit in 2Q 2022) Aug 11 Evonik Industries AG to Report Q1, 2024 Results on May 08, 2024
Evonik Industries AG Revises Financial Guidance for the Full Year 2023 Jul 12 RAG Stiftung Not in Hurry to Cut Evonik Stake Jun 09
Upcoming dividend of €1.17 per share at 5.9% yield May 25
First quarter 2023 earnings released: EPS: €0.10 (vs €0.67 in 1Q 2022) May 10
Full year 2022 earnings released: EPS: €1.16 (vs €1.61 in FY 2021) Mar 03
SABO S.p.A. acquired TAA derivatives business from Evonik Industries AG (XTRA:EVK). Dec 30
Kensing, LLC completed the acquisition of Amphoteric Surfactants and Specialty Esters Manufacturing Operations in Hopewell, Virginia from Evonik Industries AG (XTRA:EVK). Nov 02 Evonik Industries AG to Report Q2, 2023 Results on Aug 04, 2023
Second quarter 2022 earnings released: EPS: €0.64 (vs €0.48 in 2Q 2021) Aug 11
Kensing, LLC entered into an agreement to acquire Amphoteric Surfactants and Specialty Esters Manufacturing Operations in Hopewell, Virginia from Evonik Industries AG (XTRA:EVK) Aug 03
Kensing, LLC entered into an agreement to acquire Amphoteric Surfactants and Specialty Esters Manufacturing Operations in Hopewell, Virginia from Evonik Industries AG (XTRA:EVK) Aug 02
Investor sentiment deteriorated over the past week Jul 06
Evonik Industries AG, Annual General Meeting, May 31, 2023 Jun 25
Upcoming dividend of €1.17 per share May 19
First quarter 2022 earnings released: EPS: €0.67 (vs €0.41 in 1Q 2021) May 06
Evonik Industries AG Provides Earnings Guidance for the Full Year 2022 Apr 22
Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat Mar 05
Investor sentiment deteriorated over the past week Mar 04
Evonik Industries AG to Report Q4, 2022 Results on Mar 02, 2023 Mar 04
Third quarter 2021 earnings released: EPS €0.49 (vs €0.32 in 3Q 2020) Nov 06
Second quarter 2021 earnings released: EPS €0.48 (vs €0.26 in 2Q 2020) Aug 06
Evonik Industries AG (XTRA:EVK) acquired JeNaCell GmbH. Aug 04
Orion Engineered Carbons S.A. Settles Dispute with Evonik Industries AG Jun 22
Upcoming dividend of €1.15 per share May 27
First quarter 2021 earnings released: EPS €0.41 (vs €0.29 in 1Q 2020) May 08 Cassava Sciences Announces Pharmaceutical Supply Agreement for Simufilam
Full year 2020 earnings released Mar 06
Revenue beats expectations Mar 06
New 90-day high: €28.15 Feb 23
Evonik Industries AG to Report Q4, 2020 Results on Mar 04, 2021 Feb 13
New 90-day high: €27.68 Feb 01
Evonik Industries AG (XTRA:EVK) completed the acquisition of LACTEL Absorbable Polymer Product Line of DURECT Corporation (NasdaqCM:DRRX) for $15 million. Jan 06
New 90-day high: €27.34 Jan 06
New 90-day high: €26.75 Dec 16
Evonik Industries AG to Report Q2, 2021 Results on Aug 05, 2021 Dec 12
New 90-day high: €24.64 Nov 24 Evonik Industries AG to Report Q3, 2021 Results on Nov 04, 2021
Revenue beats expectations Nov 05
Third quarter 2020 earnings released: EPS €0.32 Nov 05
New 90-day low: €21.62 Nov 04
New 90-day low: €22.63 Oct 05
CVC Capital Partners Ltd. completed the acquisition of 25.01% stake in Evonik Industries AG from RAG Foundation. Sep 18
Evonik Industries AG (XTRA:EVK) entered into a definitive agreement to acquire Porocel Corporation for $210 million. Aug 27
First half earnings released Aug 04
Evonik Industries AG (XTRA:EVK) completed the acquisition of Innovativehealth Group,s.l Jul 31
United Initiators GmbH completed the acquisition of Hydrogen Peroxide (H2O2) plant of Evonik Industries AG (XTRA:EVK). Jul 30 Shareholder Returns 1EVK IT Chemicals IT Market 7D -7.5% -1.6% -2.7% 1Y -11.0% 25.0% 8.9%
See full shareholder returns
Return vs Market: 1EVK underperformed the Italian Market which returned 10.7% over the past year.
Price Volatility Is 1EVK's price volatile compared to industry and market? 1EVK volatility 1EVK Average Weekly Movement 2.8% Chemicals Industry Average Movement 3.9% Market Average Movement 4.3% 10% most volatile stocks in IT Market 7.9% 10% least volatile stocks in IT Market 2.5%
Stable Share Price: 1EVK has not had significant price volatility in the past 3 months compared to the Italian market.
Volatility Over Time: 1EVK's weekly volatility (3%) has been stable over the past year.
About the Company Evonik Industries AG produces specialty chemicals in the Asia-Pacific, Europe, the Middle East, Africa, Central and South America, and North America. It operates through Specialty Additives, Nutrition & Care, Smart Materials, Performance Materials, and Technology & Infrastructure segments. The Specialty Additives segment provides additives for polyurethane; additives, matting agents, fumed silicas, and specialty resins for paints, coatings, and printing inks; isophorone and epoxy curing agents for coatings, adhesives, and composites; and pour-point depressants, and viscosity index improvers for coatings for oil and other lubricants for construction machinery and automotive sector.
Show more Evonik Industries AG Fundamentals Summary How do Evonik Industries's earnings and revenue compare to its market cap? 1EVK fundamental statistics Market cap €7.64b Earnings (TTM ) €229.00m Revenue (TTM ) €15.16b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 1EVK income statement (TTM ) Revenue €15.16b Cost of Revenue €10.64b Gross Profit €4.52b Other Expenses €4.29b Earnings €229.00m
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Mar 05, 2025
Earnings per share (EPS) 0.49 Gross Margin 29.80% Net Profit Margin 1.51% Debt/Equity Ratio 43.2%
How did 1EVK perform over the long term?
See historical performance and comparison Dividends
7.1% Current Dividend Yield
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/19 12:21 End of Day Share Price 2024/12/19 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Evonik Industries AG is covered by 34 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Heiko Feber Bankhaus Lampe KG Anil Shenoy Barclays Andreas Heine Barclays
Show 31 more analysts